FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma | Zendy

Harri Keski–Säntti | Zendy; Timo Mustonen | Zendy; Jukka Schildt | Zendy; Kauko Saarilahti | Zendy; Antti Mäkitie | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

Author(s) -

Harri Keski–Säntti,

Timo Mustonen,

Jukka Schildt,

Kauko Saarilahti,

Antti Mäkitie

Publication year - 2014

Publication title -

clinical medicine insights ear nose and throat

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.113

H-Index - 2

ISSN - 1179-5506

DOI - 10.4137/cment.s16399

Subject(s) - medicine , head and neck squamous cell carcinoma , positron emission tomography , radiology , stage (stratigraphy) , nuclear medicine , head and neck cancer , radiation therapy , head and neck , pet ct , fluorodeoxyglucose , basal cell , predictive value , surgery , paleontology , biology

In many centers, (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is used to monitor treatment response after definitive (chemo)radiotherapy [(C)RT] for head and neck squamous cell carcinoma (HNSCC), but its usefulness remains somewhat controversial. We aimed at assessing the accuracy of FDG-PET/CT in detecting residual disease after (C)RT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research